In The News - Oncology
WCVB News Boston | February 06, 2019
WCVB's Emily Reimer explores Quanterix' next generation Simoa planar array technology.
GenomeWeb | November 08, 2018
Nov 07, 2018 | Adam Bonislawski
Enjoyed discussing the future of cancer care and the role biomarkers will play in advancing less invasive detection options, more accurate diagnoses and more personalized treatment pathways with PharmaVOICE.
GEN| October 27, 2017
Companion Diagnostic Development Gets More Complex for Immune Therapies and Other Indications Outside Oncology
DDN News | August 2017
The study, entitled “Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury,” is a proof-of-concept paper showing how the scientists combined Quanterix’s Single Molecule Array Detection technology, or Simoa, and…
Genetic Engineering and Biotechnology News | July 26, 2017
Improved Cancer Immunodiagnostics and Immunotherapeutics Depend on Biomarker Discovery
Diagnostics World | September 2, 2016
When it comes to our health, we will be most successful at advancing disease diagnostics if we can marry the benefits of genetic testing with protein testing, says Quanterix CEO and Executive Chairman, Kevin Hrusovsky. Click to read his article in Diagnostics World.
November 18, 2015
American Laboratory Read the article at www.americanlaboratory.com.
September 10, 2013
Outsourced Pharma and Clinical Leader Read the article at www.clinicalleader.com